| abstract |
The compounds of formula I, where R represents Calkoxy, optionally substituted with one or more fluorine atoms; R 1 is H or C 1 alkoxy optionally substituted with one or more fluorine atoms; R represents a 5- or 6-membered heterocyclic ring, wherein this ring is optionally substituted; R represents a 4-, 5-, 6- or 7-membered heterocyclic ring, wherein this cycle is optionally fused with a benzene ring or with a 5- or 6-membered heterocyclic ring, this cyclic system as a whole is optionally substituted; X represents CH or N; and L is absent, or is a cyclic group of formula Ia, or is a chain of formula Ib, and pharmaceutically acceptable salts thereof; used in therapy, especially in the treatment of benign prostatic hyperplasia. |